Results 71 to 80 of about 224,404 (241)
, 2006 Aim: Osteoporosis (OP) appears as a result of reduction in bone mass and deformation of micro structure is widely found in postmenopausal period. Research into etiologic risk factor and by taking required precautions may assist to prevent negative ...
Derya Demirbağ Kabayel +2 more
core
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis [PDF]
, 2004 The aim of this study was to compare the effect of once-weekly 70 mg alendronate versus once-daily 10 mg alendronate in the treatment of postmenopausal osteoporosis. Sixty-three women with postmenopausal osteoporosis were randomly assigned to two groups.
İlker Çorapçı +4 more
core
, 2022 Objective:In this study, our aimed was to investigate the frequency of neuropathic pain in women diagnosed with postmenopausal osteoporosis (OP), its effects on sleep quality, quality of life, depression and the relationship between these findings ...
Gülseren Dost Sürücü +6 more
core +1 more source
Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel +5 more
wiley +1 more source
Клинический разбор в общей медицинеThis review presents a clinical case of successful use of ibandronic acid in a patient with postmenopausal osteoporosis secondary to rheumatoid arthritis.
Ashime Sh. Asanova +7 more
doaj +1 more source
The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
, 2013 Aim: In this study, we aimed to show the correlation between the ten-year fracture risk, calculated with FRAX and bone turnover markers (BTM) in a group of postmenopausal women with osteoporosis.
Murat Uludağ +2 more
core +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Objective To investigate the factors associated with non‐vasomotor menopause symptoms among women in the UK, focusing on the perceived importance of specific symptoms and their association with demographic and treatment‐related factors. Design A cross‐sectional online survey.
Rhianna Davies +12 more
wiley +1 more source
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue +3 more
wiley +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Objective To examine the effects of Clinical Pilates (CP) training and aerobic exercise (AE) on menopausal symptoms, depressive symptoms, quality of life (QoL), and sleep quality in postmenopausal women. Design Parallel‐group randomised controlled trial. Setting A Healthy Life Center in Bitlis, Turkey.
Başak Can, Serkan Usgu, Günseli Usgu
wiley +1 more source
Is Passive Smoking a Risk Factor for Postmenopausal Osteoporosis? - Original Investigation
, 2009 Aim: We aimed to show whether or not passive smoking is a risk factor for postmenopausal osteoporosis. Material and Methods: 250 postmenopausal women between the ages 40-65, who have not had menstruated for at least one year, had FSH>40mIU/ml, have not ...
Osman Altunbayrak +4 more
core